Ahmed Seddik
3PUBLICATIONS
5CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (3)
Sort by Publication Date:
|Jul 24, 2023
Cost-effectiveness model of trastuzumab deruxtecan as second-line treatment in HER2-positive unresectable and/or metastatic breast cancer in Finland.Jeroen H J Paulissen, Ahmed H Seddik, Kyle J Dunton
|Oct 20, 2021
The Societal Economic Impact of Secukinumab in First-Line Treatment of Moderate to Severe Plaque Psoriasis in Germany: An Open-Cohort Simulation.Ahmed H Seddik, Nima Melzer, Foteini Tsotra
Pageof 1